Changes in lactate dehydrogenase on admission throughout the COVID-19 pandemic and possible impacts on prognostic capability

Introduction: The enzyme lactate dehydrogenase (LDH) is a good marker of general hyperinflammation correlated with mortality for COVID-19, and is therefore used in prognosis tools. In a current COVID-19 clinical randomized trial (CRT), the blood level of LDH was selected as an inclusion criterion. H...

Descripción completa

Detalles Bibliográficos
Autores principales: Medina-Hernández, Elba O, Pérez-Navarro, Lucía M, Hernández-Ruiz, Joselín, Villalobos-Osnaya, Alma, L Hernández-Medel, María, Casillas-Suárez, Catalina, Pérez-García, Adolfo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Preliminary Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443787/
https://www.ncbi.nlm.nih.gov/pubmed/36052694
http://dx.doi.org/10.2217/bmm-2022-0364

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9443787/
https://www.ncbi.nlm.nih.gov/pubmed/36052694
http://dx.doi.org/10.2217/bmm-2022-0364

Ejemplares similares